News in brief: PBS listing for PCSK9 inhibitor; ATAGI recommends Pfizer vaccine for children with cardiac conditions; Cardiologist blames overwork for viewing child abuse images

PBS listing for PCSK9 inhibitor The PCSK9 inhibitor alirocumab (Praluent) has been listed on the PBS from 1 August for treatment of adults with Non-Familial and Heterozygous Familial Hypercholesterolaemia. The injection is available on the PBS for patients with Non-Familial Hypercholesterolaemia who have symptomatic atherosclerotic cardiovascular disease (ASCVD), additional high-risk factors and LDL-C above 2.6 ...

Already a member?

Login to keep reading.

© 2021 the limbic